phenylalanine and 1,5-anhydroglucitol

phenylalanine has been researched along with 1,5-anhydroglucitol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kawamori, R; Miwa, S; Ohmura, C; Tanaka, Y; Watada, H1
Abdel-Hamid, AZ; El-Maraghy, SA; Hanafy, MM; Lindeque, JZ; Shahin, NN1

Trials

1 trial(s) available for phenylalanine and 1,5-anhydroglucitol

ArticleYear
Efficacy and safety of once daily gliclazide (20 mg/day) compared with nateglinide.
    Endocrine journal, 2004, Volume: 51, Issue:4

    Topics: Adult; Cross-Over Studies; Cyclohexanes; Deoxyglucose; Diabetes Mellitus, Type 2; Gliclazide; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Malondialdehyde; Nateglinide; Phenylalanine; Prospective Studies; Serum Albumin; Thiobarbituric Acid Reactive Substances

2004

Other Studies

1 other study(ies) available for phenylalanine and 1,5-anhydroglucitol

ArticleYear
Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
    BioFactors (Oxford, England), 2021, Volume: 47, Issue:4

    Topics: Animals; Biomarkers; Carnitine; Cluster Analysis; Deoxyglucose; Diabetes Mellitus, Experimental; Disease Progression; Fructose; Fucose; Galactose; Glycosuria; Inositol; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Phenylalanine; Rats; Rats, Wistar; Streptozocin; Taurine; Time Factors

2021